FDA considers first CRISPR gene editing treatment that may cure sickle cell

Re:FDA considers first CRISPR gene editing treatment that ma... by fsckboy on Monday November 20, 2023 @11:53PM (#38359443)

pricing like that only lasts as long as the patent, the argument being that without the opportunity for that pricing, the research for the drug would not be worthwhile in the first place.

I'm not arguing this is true, but I wouldn't accept a counterargument based on "but it's people, it's people, think of the children"

[ Parent | on HN ]

Re:FDA considers first CRISPR gene editing treatment that ma... by WesolyKubeczek on Tuesday November 21, 2023 @04:47AM (#38361536)

It’s probably one of the precious few arguments where “think of the children” is actually valid.

[ Parent | on HN ]

Re:FDA considers first CRISPR gene editing treatment that ma... by thaumasiotes on Tuesday November 21, 2023 @06:18AM (#38362158)

Here are some other counterarguments:

- Most formal drug research, today, is already not worthwhile. The norm is that you spend several billion dollars and recover nothing.

- Most achievements that were worthwhile in retrospect were not worthwhile prospectively. Therefore it is not obvious that things need to be worthwhile prospectively in order to be done. Going into a career as a rock star is, objectively, stupid. But we have a huge supply of wannabe rock stars anyway.

[ Parent | on HN ]